HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

8-oxocoptisine

anti-ulcerative colitis agent; structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Benzylisoquinolines: 151
    - Berberine Alkaloids: 9
      - 8-oxocoptisine: 2
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Berberine Alkaloids: 9
      - 8-oxocoptisine: 2

Experts

1.	Deng, An-Jun: 1 article (01/2014)
2.	Li, Zhi-Hong: 1 article (01/2014)
3.	Qin, Hai-Lin: 1 article (01/2014)
4.	Wang, Wen-Jie: 1 article (01/2014)
5.	Wu, Lian-Qiu: 1 article (01/2014)
6.	Yu, Jin-Qian: 1 article (01/2014)
7.	Zhang, Hai-Jing: 1 article (01/2014)
8.	Zhang, Zhi-Hui: 1 article (01/2014)
9.	Cui, Xiang Juan: 1 article (07/2012)
10.	Hai, Li: 1 article (07/2012)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2012 - "Fifteen derivatives of 8-oxocoptisine were prepared based on that 8-oxocoptisine showed potent reversing effect against human cancer cells charactering multidrug resistance (MDR). "
2.	Ulcerative Colitis 01/01/2014 - "8-Oxocoptisine showed significant anti-ulcerative colitis efficacy in vitro with EC50 value being 8.12 × 10(- 8) M. " 01/01/2014 - "New synthetic method of 8-oxocoptisine starting from natural quaternary coptisine as anti-ulcerative colitis agent."

Related Drugs and Biologics

1.	coptisine